April 2017

New Product - Aczone

Aczone (dapsone) has antiinflammatory properties which result from the inhibition of granulocyte cytotoxicity, via inhibition of peroxidases and scavenging of reactive oxygen species. The antimicrobial properties of dapsone result from competitive inhibition of dihydropteroate synthase, a bacterial enzyme necessary for synthesis of folic acid. Aczone is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Aczone is contraindicated in individuals with congenital or idiopathic methaemoglobinaemia. Aczone is available as a 7.5% w/w topical gel in 30 g, 60 g and 90 g airless pump bottles.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au